Bureau Veritas acquires Advanced Testing Laboratory, a US leader in scientific sourcing
Jun. 28 2022
Expanding BV’s footprint in Consumer Products and Consumer Healthcare markets
Bureau Veritas announced the acquisition of Advanced Testing Laboratory (ATL), a leader in scientific sourcing services for the North American Consumer Healthcare Products, Cosmetics & Personal Care and Medical Device markets.
Headquartered in Cincinnati, Ohio, ATL’s services span the entire product life cycle, from research and development to substance and product qualification to manufacturing. Services include Analytical Chemistry, Engineering, Life Science, Product Performance, Product Safety & Regulatory, Quality Assurance and Regulatory Compliance.
The company employs over 500 people all over the US. It generated revenue of approximately €31 million in 2021.
Didier Michaud-Daniel, Chief Executive Officer of Bureau Veritas, commented:
“In line with our 2025 Strategy, we are accelerating the diversification of the Consumer Products Services division into new markets and service models. Through its strong expertise in on-site scientific sourcing solutions and in lab-based services, ATL will contribute to the expansion of BV’s footprint in North America. This major step in our development enables us to enter the fast-growing Consumer Healthcare market. I would like to warmly welcome the ATL teams to Bureau Veritas.”
Greg Neal, Chief Executive Officer of Advanced Testing Laboratory, added:
“We are excited to join Bureau Veritas and look forward to expanding the services we provide our clients while sharing our unique scientific sourcing solution and framework worldwide. Through our combined expertise, we will be able to offer a unique scientific sourcing, supply chain management and ESG solution to Consumer Healthcare Products and Medical Device brands. Our clients will have access to a larger solutions support base with the ability to replicate globally, amplifying the value to our ATL client base.”